Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anectine
2. Bromide, Suxamethonium
3. Celocurine
4. Dibromide, Succinylcholine
5. Dichloride, Succinylcholine
6. Dicholine Succinate
7. Diiodide, Succinylcholine
8. Diperchlorate, Succinylcholine
9. Ditilin
10. Listenon
11. Lysthenon
12. Myorelaxin
13. Quelicin
14. Succicuran
15. Succinate, Dicholine
16. Succinylcholine
17. Succinylcholine Dibromide
18. Succinylcholine Dichloride
19. Succinylcholine Dichloride, Di H2o
20. Succinylcholine Dichloride, Di-h2o
21. Succinylcholine Diiodide
22. Succinylcholine Diperchlorate
23. Succinylcholine Iodide
24. Succinyldicholine
25. Suxamethonium
26. Suxamethonium Bromide
27. Suxamethonium Chloride
1. 71-27-2
2. Suxamethonium Chloride
3. Succinyldicholine Chloride
4. Anectine
5. Suxamethonii Chloridum
6. Lysthenon
7. Midarine
8. Quelicin
9. Scoline
10. Pantolax
11. Suxamethonium Dichloride
12. Chlorsuccinylcholin
13. Succinylcholine Dichloride
14. Succinylforte
15. Lysthenone
16. Succicuran
17. Sucostrin
18. Suxcert
19. Suxinyl
20. Bis(succinyldichlorocholine)
21. Choline Chloride Succinate (2:1)
22. Succinyl-asta
23. Scoline Chloride
24. Cloruro De Suxametonio
25. Anectine Chloride
26. Quelicin Chloride
27. Sucostrin Chloride
28. Chlorure De Succinilcoline
29. 2-dimethylaminoethyl Succinate Dimethochloride
30. Suxamethionium Chloride
31. Listenon
32. Succinoylcholine Chloride
33. Choline, Chloride Succinate
34. Choline Succinate Dichloride
35. Succinyl Bischoline Chloride
36. Succinylbischoline Dichloride
37. (2-hydroxyethyl)trimethylammonium Chloride Succinate
38. I9l0ddd30i
39. Bis(2-dimethylaminoethyl)succinate Bis(methochloride)
40. Suxamethonium Chloride [inn]
41. Chebi:61219
42. Nsc-49132
43. Succinic Acid, Diester With Choline Chloride
44. Ncgc00094357-01
45. Myoplegine
46. Sukolin
47. Succin
48. Dsstox_cid_3603
49. Diacetylcholine Dichloride
50. Dsstox_rid_77103
51. Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(n,n,n-trimethyl-), Dichloride
52. Trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium;dichloride
53. Dsstox_gsid_23603
54. Suxamethonium Chloride (inn)
55. Succinyldicholine Dichloride
56. Succamethonium Chloratum
57. Quelicin Preservative Free
58. 2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxy)]bis(n,n,n-trimethylethanaminium) Dichloride
59. Cas-71-27-2
60. Chlorsuccinylcholin [german]
61. Sukcinylcholinchlorid [czech]
62. Sukcinylcholinchlorid
63. Succinilcolina Cloruro [dcit]
64. Choline, Succinyl-, Dichloride
65. Succinilcolina Cloruro
66. Succinylcholine Chloride [usan]
67. Chlorure De Succinilcoline [french]
68. Cloruro Di Succinilcolina
69. Cloruro Di Succinilcolina [italian]
70. Suxamethonii Chloridum [inn-latin]
71. Einecs 200-747-4
72. Nsc 49132
73. Cloruro De Suxametonio [inn-spanish]
74. Unii-i9l0ddd30i
75. Ai3-51679
76. Anectine (tn)
77. Quelicin (tn)
78. Choline, Chloride, Succinate (2:1)
79. Mfcd00038725
80. Succinylcholine Chloride [usan:usp]
81. Suxamethone
82. Choline, Hydroxide, Succinate (2:1), Dihydrochloride
83. Succinyl-bis(n-(2-oxyethyl)trimethylammonium)-dichlorid
84. 3,8-dioxa-4,7-dioxodercan-1,10-bis(trimethylammonium)dichlorid
85. Succinic Acid, Bis(beta-dimethylaminoethyl) Ester, Dimethochloride
86. Chembl983
87. Schembl41536
88. Anhydrous Suxamethonium Chloride
89. Succinylcholine Chloride (usp)
90. Dtxsid1023603
91. Anhydrous Succinylcholine Chloride
92. Suxamethonium Chloride (anhydrous)
93. Hms3263g22
94. Anhydrous Succinylcholine Dichloride
95. Succinylcholine Chloride (anhydrous)
96. Tox21_111268
97. Tox21_501080
98. Anhydrous Succinyldicholine Dichloride
99. Succinylcholine Chloride [mi]
100. Succinylcholine Dichloride (anhydrous)
101. Akos015961173
102. Suxamethonium Chloride [mart.]
103. Tox21_111268_1
104. Ac-4688
105. Ccg-222384
106. Lp01080
107. Suxamethonium Chloride [who-dd]
108. Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(n,n,n-trimethyl-, Dichloride
109. Succinylcholine Chloride [vandf]
110. Succinyldicholine Dichloride (anhydrous)
111. Ncgc00015971-05
112. Ncgc00261765-01
113. Succinylcholine Chloride [usp-rs]
114. Db-055512
115. Eu-0101080
116. Suxamethonium Chloride [ep Monograph]
117. Succinylcholine Chloride [orange Book]
118. D00766
119. S 8251
120. Succinylcholine Chloride [usp Monograph]
121. Sr-01000075346
122. Q-201750
123. Sr-01000075346-2
124. Q12455154
Molecular Weight | 361.3 g/mol |
---|---|
Molecular Formula | C14H30Cl2N2O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 360.1582628 g/mol |
Monoisotopic Mass | 360.1582628 g/mol |
Topological Polar Surface Area | 52.6 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 284 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Quelicin preservative free |
Active Ingredient | Succinylcholine chloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 100mg/ml |
Market Status | Prescription |
Company | Hospira |
2 of 2 | |
---|---|
Drug Name | Quelicin preservative free |
Active Ingredient | Succinylcholine chloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 100mg/ml |
Market Status | Prescription |
Company | Hospira |
Neuromuscular Depolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation. (See all compounds classified as Neuromuscular Depolarizing Agents.)
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-03-02
Pay. Date : 2018-02-12
DMF Number : 23224
Submission : 2009-10-29
Status : Active
Type : II
NDC Package Code : 11712-830
Start Marketing Date : 2006-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-05-02
Pay. Date : 2023-02-16
DMF Number : 37095
Submission : 2022-12-15
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-15
Pay. Date : 2017-10-06
DMF Number : 31986
Submission : 2017-10-11
Status : Active
Type : II
Registration Number : 304MF10080
Registrant's Address : 107-A, Vinay Bhavya Complex, 159-A, C. S. T Road, Kalina, Santa Cruz (East), Mumbai-400 098, Maharashtra, India
Initial Date of Registration : 2022-05-25
Latest Date of Registration : --
Date of Issue : 2022-06-06
Valid Till : 2025-07-21
Written Confirmation Number : WC-0044
Address of the Firm :
NDC Package Code : 66064-1028
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2014-03-18
DMF Number : 22892
Submission : 2009-06-24
Status : Active
Type : II
Certificate Number : CEP 2013-210 - Rev 01
Issue Date : 2024-05-30
Type : Chemical
Substance Number : 248
Status : Valid
Date of Issue : 2021-08-06
Valid Till : 2024-03-04
Written Confirmation Number : WC-0294
Address of the Firm :
NDC Package Code : 72643-002
Start Marketing Date : 2011-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25440
Submission : 2011-10-31
Status : Active
Type : II
Certificate Number : CEP 2012-025 - Rev 03
Issue Date : 2024-07-17
Type : Chemical
Substance Number : 248
Status : Valid
Date of Issue : 2021-01-22
Valid Till : 2023-08-01
Written Confirmation Number : WC-0275
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-08-29
Pay. Date : 2022-08-18
DMF Number : 37245
Submission : 2022-07-25
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-05-13
Pay. Date : 2020-04-22
DMF Number : 34619
Submission : 2020-02-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7365
Submission : 1988-02-28
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Succinylcholine Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Succinylcholine Chloride, including repackagers and relabelers. The FDA regulates Succinylcholine Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Succinylcholine Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Succinylcholine Chloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Succinylcholine Chloride supplier is an individual or a company that provides Succinylcholine Chloride active pharmaceutical ingredient (API) or Succinylcholine Chloride finished formulations upon request. The Succinylcholine Chloride suppliers may include Succinylcholine Chloride API manufacturers, exporters, distributors and traders.
click here to find a list of Succinylcholine Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Succinylcholine Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Succinylcholine Chloride active pharmaceutical ingredient (API) in detail. Different forms of Succinylcholine Chloride DMFs exist exist since differing nations have different regulations, such as Succinylcholine Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Succinylcholine Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. Succinylcholine Chloride USDMF includes data on Succinylcholine Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Succinylcholine Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Succinylcholine Chloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Succinylcholine Chloride Drug Master File in Japan (Succinylcholine Chloride JDMF) empowers Succinylcholine Chloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Succinylcholine Chloride JDMF during the approval evaluation for pharmaceutical products. At the time of Succinylcholine Chloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Succinylcholine Chloride suppliers with JDMF on PharmaCompass.
A Succinylcholine Chloride CEP of the European Pharmacopoeia monograph is often referred to as a Succinylcholine Chloride Certificate of Suitability (COS). The purpose of a Succinylcholine Chloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Succinylcholine Chloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Succinylcholine Chloride to their clients by showing that a Succinylcholine Chloride CEP has been issued for it. The manufacturer submits a Succinylcholine Chloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Succinylcholine Chloride CEP holder for the record. Additionally, the data presented in the Succinylcholine Chloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Succinylcholine Chloride DMF.
A Succinylcholine Chloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Succinylcholine Chloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Succinylcholine Chloride suppliers with CEP (COS) on PharmaCompass.
A Succinylcholine Chloride written confirmation (Succinylcholine Chloride WC) is an official document issued by a regulatory agency to a Succinylcholine Chloride manufacturer, verifying that the manufacturing facility of a Succinylcholine Chloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Succinylcholine Chloride APIs or Succinylcholine Chloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Succinylcholine Chloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Succinylcholine Chloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Succinylcholine Chloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Succinylcholine Chloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Succinylcholine Chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Succinylcholine Chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Succinylcholine Chloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Succinylcholine Chloride suppliers with NDC on PharmaCompass.
Succinylcholine Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Succinylcholine Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Succinylcholine Chloride GMP manufacturer or Succinylcholine Chloride GMP API supplier for your needs.
A Succinylcholine Chloride CoA (Certificate of Analysis) is a formal document that attests to Succinylcholine Chloride's compliance with Succinylcholine Chloride specifications and serves as a tool for batch-level quality control.
Succinylcholine Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Succinylcholine Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Succinylcholine Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Succinylcholine Chloride EP), Succinylcholine Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Succinylcholine Chloride USP).
LOOKING FOR A SUPPLIER?